首页/数据集/Reduction from list price of pharmaceutical products by manufacturer U.S. 2022

Reduction from list price of pharmaceutical products by manufacturer U.S. 2022

Statista2026-04-25 收录

药品定价分析

生物制药市场

数据链接：

https://www.statista.com/statistics/1310703/drug-list-price-reduction-by-manufacturer-us/数据链接链接失效反馈

官方服务：

资源简介：

Average reduction from list price of pharmaceutical products in the U.S. in 2022, by manufacturer

应用场景：

生物制药市场

市场预测

The global Remicade biosimilar market size was worth USD 1,628.3 million in 2021 and is estimated to grow to USD 10,257.7 million by 2028, with a CAGR of 35.9.

www.zionmarketresearch.com2024-11-22 更新70

Trastuzumab prices in Brazil and Slovenia

药品定价分析

跨国医疗差异

Trastuzumab prices in Brazil and Slovenia

Harvard Dataverse2024-07-12 更新40

North America Fibroblast Growth Factor Receptor 3 (FGFR3) ELISA Kit Market

FGFR3

生物制药市场

The report on North America Fibroblast Growth Factor Receptor 3 (FGFR3) ELISA Kit covers a summarized study of several factors supporting market growth, such as market size, market type, major regions

IMR REPORTS30

North America Specialty Enzymes Market

酶市场分析

生物制药市场

The report on North America Specialty Enzymes covers a summarized study of several factors supporting market growth, such as market size, market type, major regions, and end-user applications. The rep

IMR REPORTS50

Nanobody Market

纳米抗体技术

生物制药市场

Technological advancements in the Nanobody industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transforming industry pract

IMR REPORTS40

Reduction from list price of pharmaceutical products by manufacturer U.S. 2022

资源简介：

相关数据集